In this article CRM VRTX LEN Salesforce signage outside office building in New York. Scott Mlyn | CNBC Check out the companies making headlines in midday trading Wednesday: Allbirds — Allbirds shares sunk more than 13% after the shoe maker’s losses grew in the third quarter, even as its revenue rose from last year. The quarterly
The United Nations COP26 summit recently highlighted the fact that “human activities have caused around 1.1°C of global warming to date” and the “impacts are already being felt in every region.” Over the next few decades, countries need to work towards minimizing and potentially reversing the damage to the climate. Green energy stocks are therefore
Deciphera Pharmaceuticals (NASDAQ:DCPH) is a biotech company that develops drugs mainly for the treatment of cancer. Right now, DCPH stock shares are down nearly 85% year-to-date (YTD), at $7.70 as of the close of Nov. 29. Source: Iryna Imago / Of course, with Thanksgiving just over, it’s probably appropriate to note that I’m thankful for
How Your Roth IRA Contribution Limit Is Calculated The primary factors for determining your contribution limit are your filing status and modified adjusted gross income (MAGI), which is your income after considering certain allowable deductions and tax penalties. Based on these two factors, you may be eligible to contribute the max, a reduced amount, or
When you chase after a stock that has gone too far without justification, you’re likely to get punished. That’s a lesson learned by many of Jumia Technologies’ (NYSE:JMIA) shareholders, as JMIA stock has been taking a beating lately. Source: farzand01 / As the old saying goes, the trend is your friend. There’s nothing friendly about
In this article NCLH AAL BYND BNTX An American Airlines plane lands at Ronald Reagan Washington National Airport November 23, 2021 in Arlington, Virginia. Drew Angerer | Getty Images Check out the companies making headlines in midday trading Tuesday. American Airlines, Norwegian Cruise Line — Travel stocks retreated, as investors continued to weigh the risks
CNBC’s Jim Cramer said he doesn’t feel comfortable buying into Monday’s early stock market bounce, following Friday’s omicron-driven plunge, because the selling could resume in the event of future negative news about the highly mutated Covid variant. The Dow Jones Industrial Average — which had been up nearly 400 points, or more than 1%, shortly